These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33344188)

  • 1. Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema.
    Şahin AK; Kükner AŞ; Ulaş F; Doğan Ü
    Int J Ophthalmol; 2020; 13(12):1901-1907. PubMed ID: 33344188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
    Wolf EJ; Braunstein A; Shih C; Braunstein RE
    J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
    Mathys KC; Cohen KL
    Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
    Campa C; Salsini G; Perri P
    Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
    Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR
    J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and anatomical evaluation of the effect of nepafenac in prevention of macular edema after phacoemulsification in diabetic patients.
    Mokbel T; Saleh S; Abdelkader M; El-Khouly SE; Abou Samra W; Mamdouh M
    Int J Ophthalmol; 2019; 12(3):387-392. PubMed ID: 30918805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
    Cardascia N; Palmisano C; Centoducati T; Alessio G
    Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients.
    Alnagdy AA; Abouelkheir HY; El-Khouly SE; Tarshouby SM
    Int J Ophthalmol; 2018; 11(4):616-622. PubMed ID: 29675380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
    Danni R; Viljanen A; Aaronson A; Tuuminen R
    Acta Ophthalmol; 2019 Sep; 97(6):589-595. PubMed ID: 30620140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
    McCafferty S; Harris A; Kew C; Kassm T; Lane L; Levine J; Raven M
    BMC Ophthalmol; 2017 Feb; 17(1):16. PubMed ID: 28219426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
    Sengupta S; Vasavada D; Pan U; Sindal M
    Indian J Ophthalmol; 2018 Jun; 66(6):827-830. PubMed ID: 29785993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macular edema after an uncomplicated cataract surgery].
    Jurecka T; Bátková Z; Ventruba J
    Cesk Slov Oftalmol; 2007 Jul; 63(4):262-73. PubMed ID: 17682606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site.
    Cable M
    Clin Ophthalmol; 2012; 6():997-1004. PubMed ID: 22815642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema.
    Giarmoukakis AK; Blazaki SV; Bontzos GC; Plaka AD; Seliniotakis KN; Ioannidi LD; Tsilimbaris MK
    Ther Clin Risk Manag; 2020; 16():1067-1074. PubMed ID: 33192068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac.
    Cervantes-Coste G; Sánchez-Castro YG; Orozco-Carroll M; Mendoza-Schuster E; Velasco-Barona C
    Clin Ophthalmol; 2009; 3():219-26. PubMed ID: 19668569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified Topical Steroids as Prophylaxis for Macular Edema After Posterior Lamellar Keratoplasty Combined With Cataract Surgery.
    Hoerster R; Stanzel TP; Bachmann BO; Siebelmann S; Felsch M; Cursiefen C
    Am J Ophthalmol; 2016 Mar; 163():174-179.e2. PubMed ID: 26701270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification.
    Chinchurreta Capote AM; Lorenzo Soto M; Rivas Ruiz F; Caso Peláez E; García Vazquez A; ; Ramos Suárez A
    Int J Ophthalmol; 2018; 11(7):1210-1216. PubMed ID: 30046541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy.
    Singh R; Alpern L; Jaffe GJ; Lehmann RP; Lim J; Reiser HJ; Sall K; Walters T; Sager D
    Clin Ophthalmol; 2012; 6():1259-69. PubMed ID: 22927737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
    Warren KA; Fox JE
    Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of macular thickness change by optical coherence tomography after uncomplicated cataract surgery in eyes with and without exfoliation syndrome.
    Kemer Atik B; Kirmaci Kabakci A; Garip R
    Int Ophthalmol; 2021 Feb; 41(2):519-526. PubMed ID: 33057867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.